Le Lézard
Classified in: Health
Subjects: LAW, PLW

Puritan Secures Another Legal Victory Against Copan in Sweden

Italian competitor's infringement claims rebutted once again, marking its sixth defeat to date

GUILFORD, Maine, Jan. 4, 2023 /PRNewswire/ -- Today, Puritan Medical Products?the world's most trusted manufacturer of swabs and specimen collection and transport devices ?is proud to celebrate yet another affirmation of patent law, this time in Sweden. The Swedish patent lawsuit filed by Italian swab-maker Copan Italia S.p.A. hit a dead end earlier this month, with the Swedish Court of Appeals confirming that Puritan's flocked swabs do not infringe any claims of Copan's European Patent that supposedly protects the Italian company's core flocked swab technology.

Copan launched a patent offensive against Puritan distributor Svenska LABFAB in Sweden back in April 2019, after losing a competitive bid in Sweden. The Italian company announced the Swedish lawsuit during a trade show in the Netherlands, handing out flyers claiming "that Svenska LABFAB has committed a willful infringement of the patent covering COPAN's core flocked swab technology." By June 2020, however, the Swedish courts sided with LABFAB and handed Copan a resounding defeat. LABFAB successfully defeated the infringement claims and even earned legal fees for its efforts.

Later that year, in November 2020, Puritan similarly defeated the Italian competitor in a string of German lawsuits and appeals, also earning legal fees. Fast forward to 2022, and Copan suffered another defeat at the hands of the International Trade Commission (ITC) in Washington, D.C. In that case, Copan accused rival Chinese swab makers of infringing its patents, only for the claims to be denied by an ITC judge. Copan has now lost six lawsuits in which it asserted flocked swab patent infringement.

"Heading into 2023, Puritan's hard-working team can celebrate yet another legal victory that upholds patent law," said Bob Shultz, President and CFO at Puritan. "Copan's latest defeat is a strong message to our entire industry that good-faith business practices are paramount in this day and age. We are happy that this most recent distraction is now behind us, as we look ahead to doing right by our customers in the new year."

To schedule an interview, please contact Virginia Templet, [email protected].

Logo - https://mma.prnewswire.com/media/703607/Puritan_Medical_Logo.jpg

These press releases may also interest you

at 07:50
Avicanna Inc. ("Avicanna" or the "Company) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that Shoppers Drug Mart® ("Shoppers") has...

at 07:50
Evaxion Biotech A/S ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the discovery and development of AI-powered...

at 07:35
Sonoma Biotherapeutics, Inc. and Regeneron Pharmaceuticals, Inc. today announced a collaboration to apply their scientific and clinical expertise and respective technology platforms to the discovery, development and commercialization of novel...

at 07:30
Digital Diagnostics ? a leading AI diagnostics company on a mission to transform global healthcare ? has rebranded its flagship product, the AI diagnostic system formerly known as IDx-DR, to LumineticsCoretm....

at 07:30
Pathway Health Corp. ("Pathway" or the "Company") is pleased to announce that, further to its press releases of February 3, 2023, February 9, 2023 and February 17, 2023, it has made its third and final draw in the amount of $250,000 (the "Draw...

at 07:25
United Network for Organ Sharing (UNOS) has rolled out a new organ allocation system designed to be more equitable and effective for patients in need of lung transplants....

News published on 4 january 2023 at 07:30 and distributed by: